JIANG, D. M. .; HAMILTON, R. J. .; HANSEN, A. R. . Chemotherapy intensification for first-line treatment of poor-prognosis metastatic germ cell cancer is not yet ready for prime time . Canadian Urological Association Journal, [S. l.], v. 14, n. 2, p. 48–9, 2020. DOI: 10.5489/cuaj.6407. Disponível em: https://cuaj.ca/index.php/journal/article/view/6407. Acesso em: 23 apr. 2024.